Which polymers are used in ocular drug delivery system?
Common biological polymers in use for ocular biomaterials and drug delivery systems include cellulose, chitosan, hyaluronic acid (HA), collagen, carboxymethyl cellulose (CMC), gelatin, dextran, guar gum, pullulan, and polydopamine.
What is ocular drug delivery system?
Ocular drug delivery system (ODDS) is a dosage form, vehicle, or system intended for instilling, administering, or delivering drug/medicine to eye against any ailment or disorder involving or affecting vision. It ranges from simple sterile eye drop for the ocular surface to complex implants for intraocular tissue.
What is an Ocusert?
Ocuserts are the new drug delivery systems which are designed in such a way that they release the drug at predetermined and predictable rates thus eliminating the frequent administration of the drug.
What kind of polymers can be used in gel forming ophthalmic preparations?
At lower pH (pH 4.4), the formulation exists as a regular solution, however, it undergoes gel formation at pH 7.4, that is the pH of tear fluid. The most commonly used pH-responsive polymers in ophthalmic preparation are Polyacrylic acid (PAA, Carbopol 940), polycarbophil, and cellulose acetate phthalate (CAP) [17].
Which is matrix type ocular system?
Matrix type drug delivery systems: These are the devices that have the therapeutic agent, which is incorporated or impregnated with in the polymer, for controlled release of drug. E.g.; Hydrophilic soft contact lenses, soluble ocular inserts ( 9).
What is Ocusert system?
➢Ocular insert (Ocusert) are sterile preparation that. prolong residence time of drug with a controlled release manner and negligible or less affected by nasolacrimal drainage. ➢It shows diffusion controlled release. ➢It consists of a central reservoir of drug enclosed in. specially designed microporous membrane …
What are the advantages of Nanodrug delivery system?
Enhanced delivery to the tumor site; Decreased side effects and systemic toxicity. Improved efficacy by controlled delivery of the therapeutic agent. Targeted and controlled release of the drug, improved anticancer efficacy, decreased systemic toxicity. Enhanced solubility; Increased delivery to the tumor.
What is Ocusert example?
A brand name for a device that leaches PILOCARPINE into the conjunctival sac, for the treatment of GLAUCOMA.
Which of the following erodible insert is used in the treatment of dry eye syndrome?
Lacrisertis: Lacrisertis are sterile, pole molded erodible which is produced using hydroxypropyl cellulose. It is used for the treatment of dry eye syndrome without any preservatives. Lacrisert is useful in the treatment of Keratitis. Lacrisert which decrease the corneal sensitivity and corneal erosions.
What is situ gel?
In situ gelling systems are polymeric formulations that are in sol forms before entering in the body, but change to gel forms under the physiological conditions.
What is hydrogel drug delivery?
Hydrogel delivery systems can leverage therapeutically beneficial outcomes of drug delivery and have found clinical use. Hydrogels can provide spatial and temporal control over the release of various therapeutic agents, including small-molecule drugs, macromolecular drugs and cells.
Why is modified ocular drug delivery system needed?
For ocular delivery, it provides several advantages such as sterilization, ease of eye drop formulation, less irritation, increase precorneal residence time and enhancement in ocular bioavailability of drugs which are insoluble in tear fluid.
What is lacrisert used for?
This medication is an insert that is placed in your eye to treat dry eyes. It is usually used when an artificial tears solution is not successful. This medication may also be used to treat certain other eye disorders (keratitis, decreased corneal sensitivity).
What are non erodible inserts?
The Non-erodible ocular inserts include Ocusert, and Contact lens. In the bioerosion mechanism, the insert is comprised of a matrix of bioerodible material in which the drug is dispersed. Contact of the insert with the tear fluid results in controlled sustained release of the drug by bioerosion of the matrix.
Is nanoparticulate cyclosporine hemocompatibility in vitro?
These particulate carriers exhibited controlled in vitro release of cyclosporine for 23 days at a nearly constant rate and showed very good hemocompatibility in vitro. The nanoparticulate formulation showed significantly higher intestinal uptake as compared to Sandimmune Neoral and cyclosporine suspension.
Can nanoparticulate drug delivery revolutionize the treatment landscape of retinal diseases?
The nanoparticulate drug delivery system confers the capability for delivering therapeutics to the specific ocular targets and, hence, potentially revolutionizes the current treatment landscape of retinal diseases.
How are cyclosporine-loaded poly (lactide-co-glycolide) nanoparticles prepared?
The cyclosporine-loaded poly (lactide-co-glycolide) (PLGA) nanoparticles (NPs) were prepared by the emulsion-diffusion-evaporation method and were optimized for particle size and entrapment efficiency. The optimized particles were 143. 3+/-8. 7 nm in size with narrow size distribution and 71. 9+/-1.
Are liposomes the best nanoparticles for posterior segment Eye?
Nowadays, liposomes represent the most utilized nanoparticles for eye drug delivery and, recently, a broad spectrum of diverse nanoparticles continue to emerge with special characteristics representing ideal candidates for eye drug delivery. Keywords: Biotechnology, Eye diseases, Liposomes, Nanoparticles, Posterior segment eye